Ethnicity, genetic testing exposure, knowledge about

breast cancer genetics genetic testing, https://www.selleckchem.com/products/MDV3100.html attitudes about the benefits, limitations, and risks of genetic testing. Compared to Caucasian women, AfAm women had lower levels of knowledge about genetic testing. 23 % of AfAm women rated “concern about the effect on their family” as very important, compared with 13 % of Caucasian women. Hughes, Fasaye et al. (2003) 28 (100 %) Minimum 10-20 % prior probability of having a BRCA1/2 mutation Sociocultural influences on participation in genetic testing among AfAm women. Baseline interviews were conducted followed by education Selleck GSK1120212 sessions and genetic testing. A two week follow-up interview assessed associations between cultural beliefs and values and participation in genetic testing. Attitudes towards benefits and limitations of genetic testing, fatalistic beliefs about cancer. Women participating in genetic testing were more likely to have a high level of fatalistic beliefs about cancer, report a future temporal orientation, and view themselves as independent from family members, compared with non-participants. Kessler et al. (2005) 74 (100 %) 5–10 % probability of having a BRCA1/2 mutation

Evaluated attitudes about the Capmatinib datasheet benefits, limitations, and risks of genetic testing. Clinical factors, beliefs about cancer, perceptions of risk and control, attitudes and intentions regarding genetic testing. Higher levels of fatalistic beliefs about cancer were associated with greater consideration and uptake of genetic testing. Lerman, Hughes et al. (1999) 228 (23 %; 70) At least one FDR with breast and/or ovarian cancer; no personal cancer history Telephone interviews in a RCT were used to assess racial differences in responses to pre-test education strategies for BRCA1 genetic testing. Risk comprehension, genetic testing intention, breast cancer anxiety.

AfAm women benefited from the combined provision of genetic risk information and counseling more than Caucasian women. AfAms who received the education and counseling intervention reported greater intentions to be Edoxaban tested in the future and were more likely to donate a blood sample for storage. Lipkus et al. (1999) 266 (100 %) At least one FDR with breast cancer Examined relationships among perceptions of, and concern about, getting breast cancer and interest in genetic testing. Perceptions and attributions of risk, knowledge of risk factors, breast cancer concerns, interest in genetic testing. Increasing perceptions of breast cancer risks and concerns were related to a greater interest in genetic testing. Matthews, Cummings et al. (2000) 21 (62 %; 13) No criteria specified Qualitative research. Focus groups were conducted to learn more about factors influencing participation of AfAms in genetic testing.